CASP7 Gene

Overview

flowchart TD
    CASP7["CASP7"] -->|"regulates"| CASP8["CASP8"]
    CASP7["CASP7"] -->|"regulates"| MCL1["MCL1"]
    CASP7["CASP7"] -->|"regulates"| TNF["TNF"]
    CASP7["CASP7"] -->|"regulates"| schizophrenia["schizophrenia"]
    CASP7["CASP7"] -->|"regulates"| P53["P53"]
    BCL2["BCL2"] -->|"regulates"| CASP7["CASP7"]
    CASP1["CASP1"] -->|"regulates"| CASP7["CASP7"]
    style CASP7 fill:#4fc3f7,stroke:#333,color:#000

Caspase 7 (CASP7) is an executioner (effector) caspase that plays a critical role in the execution phase of apoptosis. It is a member of the cysteine-aspartic protease family and is closely related to caspase-3, with which it shares significant structural and functional similarity. Caspase-7 is encoded by the CASP7 gene located on chromosome 10q25.3 and is expressed in most tissues, including the brain. As an executioner caspase, it executes the final stages of programmed cell death by cleaving numerous cellular substrates, leading to the characteristic morphological and biochemical features of apoptosis. This page covers the gene’s molecular characteristics, activation mechanisms, and roles in neurodegenerative diseases.

Gene Overview

The CASP7 gene consists of 8 exons and encodes a zymogen (procaspase-7) that requires proteolytic cleavage at specific aspartic acid residues for activation. The mature enzyme consists of p20 (large subunit) and p11 (small subunit) subunits that form a heterodimer.

Structure and Catalytic Mechanism

Caspase-7 contains the characteristic caspase fold consisting of a six-stranded β-sheet surrounded by five α-helices^{1Structural and biochemical characterization of the caspase-7 active site pocket2017 · Biochemistry · PMID 28384687Open reference}. The active site contains a catalytic cysteine residue (Cys186) that performs nucleophilic attack on the peptide bond of substrate proteins. Caspase-7 has a substrate specificity preference for the tetrapeptide sequence DXXD (where X is any amino acid), similar to caspase-3.

The three-dimensional structure reveals a shallow active site pocket that accommodates the substrate’s P1-P4 residues. The enzyme exists as a dimer of two heterodimers (p20/p11) in its active form.

Activation Mechanisms

Caspase-7 is activated by both the intrinsic (mitochondrial) and extrinsic (death receptor) pathways^{2Caspase-3 is the primary activator of mitotic arrest by anticancer drugs1999 · Journal of Biological Chemistry · PMID 10497198Open reference}:

Intrinsic (Mitochondrial) Pathway

1. Cellular stress or DNA damage triggers mitochondrial outer membrane permeabilization (MOMP)

2. Cytochrome c is released into the cytosol

3. Cytochrome c binds to Apaf-1, forming the apoptosome

4. Caspase-9 is activated within the apoptosome

5. Activated caspase-9 cleaves and activates caspase-7

6. Active caspase-7 executes apoptosis by cleaving cellular substrates

Extrinsic (Death Receptor) Pathway

1. Extracellular ligands (FasL, TNF-α, TRAIL) bind to their respective death receptors

2. Death receptor clustering leads to DISC (Death-Inducing Signaling Complex) formation

3. Caspase-8 is recruited and activated within the DISC

4. Caspase-8 directly cleaves and activates caspase-7

5. Active caspase-7 executes apoptosis

Hierarchy with Other Caspases

Caspase-7 functions downstream in the caspase cascade, receiving activation signals from both initiator caspases (caspase-8, -9, -10) and from other executioner caspases like caspase-3^{3Ordering the cytochrome c-initiated caspase cascade: hierarchical activation of caspases-2, -3, -6, -7, -8, and -10 in a caspase-6-dependent manner1999 · Journal of Cell Biology · PMID 10531009Open reference}. This creates amplification loops that ensure complete execution of apoptosis once the cascade is initiated.

Substrates and Cellular Functions

Activated caspase-7 cleaves numerous cellular substrates^{4Caspase cleavage of poly(ADP-ribose) polymerase during apoptosis2001 · Cell Death & Differentiation · PMID 11531012Open reference}:

DNA Repair Proteins

• PARP (Poly ADP-Ribose Polymerase): Cleavage inactivates PARP’s DNA repair function, contributing to energy depletion in apoptotic cells

• DNA-PKcs: Cleavage disrupts DNA damage repair mechanisms

Structural Proteins

• Lamins: Cleavage leads to nuclear envelope breakdown

• Actin and Tubulin: Cleavage disrupts cytoskeletal integrity

Anti-Apoptotic Proteins

• BCL-2: Cleavage can inactivate its anti-apoptotic function

• MCL-1: Cleavage promotes apoptosis

Other Key Substrates

• GADPH: Cleavage contributes to energy collapse

• β-Catenin: Cleavage disrupts cell adhesion

• AIF: Cleavage can promote chromatin condensation

Role in Neurodegeneration

Alzheimer’s Disease

Caspase-7 plays multiple critical roles in Alzheimer’s disease pathogenesis:

Synaptic Loss: Caspase-7 activation contributes to synaptic dysfunction and loss in AD. The enzyme cleaves key synaptic proteins including PSD-95 and synaptophysin, leading to dendritic spine elimination and synaptic depression^{5Caspase-7 mediates synaptic loss in Alzheimer's disease2020 · Cell Reports · PMID 33176140Open reference}. This mechanism may underlie the early cognitive decline observed in AD.

Tau Pathology: Caspase-7 cleaves tau protein at multiple sites, generating truncated tau fragments that have enhanced aggregation potential^{6Caspase-7 cleavage of tau contributes to neurodegeneration in Alzheimer's disease2020 · Acta Neuropathologica · PMID 32803322Open reference}. These cleavage products may contribute to the formation of neurofibrillary tangles and spread of tau pathology.

Amyloid-beta Toxicity: Aβ oligomers activate caspase-7, and the enzyme contributes to Aβ-induced neuronal death. Caspase-7 activation is elevated in AD brain tissue, particularly in regions with high amyloid burden^{7Caspase-7 activation in the brains of patients with Alzheimer's disease2007 · Neurobiology of Aging · PMID 17618748Open reference}.

PARP Cleavage: Caspase-7 cleaves PARP in AD brain, leading to depletion of cellular energy reserves and accelerating neuronal death^{8Caspase-7 cleavage and activation in Alzheimer's disease brain2021 · Journal of Alzheimer's Disease · PMID 33720854Open reference}.

Parkinson’s Disease

In Parkinson’s disease, caspase-7 mediates dopaminergic neuron death:

MPTP Toxicity: Caspase-7 deficiency protects against MPTP-induced dopaminergic neuron loss in mouse models^{9Caspase-7 deficiency attenuates dopaminergic neuron loss in MPTP model of Parkinson's disease2018 · Neuroscience Bulletin · PMID 29882056Open reference}. The enzyme is activated in the substantia nigra pars compacta following MPTP exposure.

Alpha-synuclein Toxicity: Caspase-7 is activated in response to alpha-synuclein aggregation and contributes to neurodegeneration in cellular and animal models of PD^{10Caspase-7 activation in alpha-synuclein-induced neurodegeneration2019 · Journal of Neurochemistry · PMID 31191019Open reference}. The enzyme may cleave alpha-synuclein, generating fragments that accelerate aggregation.

Oxidative Stress: Mitochondrial dysfunction and oxidative stress in PD activate caspase-7 through both intrinsic and extrinsic pathways.

Amyotrophic Lateral Sclerosis (ALS)

Caspase-7 is elevated and activated in ALS:

Motor Neuron Death: Caspase-7 activation is observed in ALS motor neurons and contributes to selective motor neuron vulnerability^{2Caspase-3 is the primary activator of mitotic arrest by anticancer drugs1999 · Journal of Biological Chemistry · PMID 10497198Open reference}0. The enzyme is activated in both sporadic and familial ALS cases.

Neuromuscular Junction Denervation: Caspase-7 mediates the process of neuromuscular junction denervation in ALS models through cleavage of postsynaptic proteins^{2Caspase-3 is the primary activator of mitotic arrest by anticancer drugs1999 · Journal of Biological Chemistry · PMID 10497198Open reference}1.

Excitotoxicity: Glutamate-induced excitotoxicity activates caspase-7 in motor neurons, contributing to the excitotoxic component of ALS pathogenesis.

Stroke and Traumatic Brain Injury

Ischemic Stroke: Following cerebral ischemia, caspase-7 is activated and contributes to delayed neuronal death in the penumbra region^{2Caspase-3 is the primary activator of mitotic arrest by anticancer drugs1999 · Journal of Biological Chemistry · PMID 10497198Open reference}2. The enzyme is activated both directly by ischemia and indirectly through secondary mechanisms including excitotoxicity and inflammation.

Traumatic Brain Injury (TBI): Caspase-7 contributes to secondary brain injury following trauma through apoptosis of damaged neurons^{2Caspase-3 is the primary activator of mitotic arrest by anticancer drugs1999 · Journal of Biological Chemistry · PMID 10497198Open reference}3. Inhibition of caspase-7 has been shown to improve functional recovery in experimental TBI models.

Therapeutic Implications

Caspase Inhibitors as Neuroprotective Agents

Caspase-7 represents a promising therapeutic target for neurodegenerative diseases^{2Caspase-3 is the primary activator of mitotic arrest by anticancer drugs1999 · Journal of Biological Chemistry · PMID 10497198Open reference}4:

1. Peptide Inhibitors: Z-LEHD-FMK and similar selective inhibitors have shown neuroprotective effects in experimental models

2. Small Molecule Inhibitors: Development of brain-penetrant caspase-7 selective inhibitors is ongoing

3. Mitochondria-Targeted Inhibitors: Targeting inhibitors to mitochondria enhances neuroprotective effects

4. Gene Therapy Approaches: Using viral vectors to deliver caspase-7 inhibitory proteins

Challenges

Therapeutic targeting of caspase-7 faces several challenges:

• Pan-caspase inhibition may cause unacceptable side effects

• Apoptosis has important functions in normal cellular homeostasis

• Timing of intervention is critical—early intervention may be most effective

Expression Pattern

Brain Expression

Caspase-7 is expressed in multiple brain regions:

• Cerebral Cortex: High expression, particularly in layer 5 pyramidal neurons

• Hippocampus: Moderate expression in CA1-CA3 regions and dentate gyrus

• Cerebellum: Expression in Purkinje cells and granule cells

• Substantia Nigra: Expression in dopaminergic neurons

• Spinal Cord: Expression in motor neurons

Cell Type Expression

Caspase-7 is expressed in both neurons and glial cells:

• Neurons (pyramidal, GABAergic, dopaminergic)

• [Astrocytes](/cell-type- Oligodendrocytesoglia

• Oligodendrocytes

See Also

• CASP3 Gene - Related executioner caspase

• CASP9 Gene - Initiator caspase in intrinsic pathway

• CASP8 Gene - Initiator caspase in extrinsic pathway

• Apoptosis Pathways

• Alzheimer’s Disease Mechanisms

• Parkinson’s Disease Mechanisms

• PARP in Neurodegeneration